1
results found
Purpose To develop and verify a physiologically based pharmacokinetic (PBPK) modeling strategy for mithramycin (MTM) and its analog, MTMSA-Trp, with the aim of projecting first-in-human plasma pharmac...
Physiologically based pharmacokinetic model
First-in-human dose prediction
Interspecies scaling
Mithramycin analog
Ewing sarcoma
SinoXiv